Suppr超能文献

决定囊性纤维化携带者筛查:三个公民陪审团和一项在线调查。

Deciding on cystic fibrosis carrier screening: three citizens' juries and an online survey.

机构信息

Laboratory for Medical Research and Consumers Involvement, Department of Public Health, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

Zadig Agenzia di Editoria Scientifica, Milan, Italy.

出版信息

Eur J Public Health. 2018 Oct 1;28(5):973-977. doi: 10.1093/eurpub/cky032.

Abstract

BACKGROUND

Health technology assessment and ethical issues have to be dealt with in deciding on national carrier screening for cystic fibrosis (CF)-the most frequent severe autosomal recessive disease in Caucasian populations and several stakeholders need to be involved. A citizens' jury is one way to ask citizens to deliberate on controversial topics in the interests of a society. The aims of this project were to gather opinions about CF carrier screening through citizens' jury deliberations and to match them with the findings of a large online consultation survey open to the general population, people with CF and families and health professionals.

METHODS

Three citizens' juries and an online survey were asked: 'Should the Health Service organize screening of the population with the aim of identifying healthy people who may have children with CF?' The jurors had no medical background and no personal or family CF history. The survey was open to people with CF, families, and healthcare professionals.

RESULTS

Jurors and survey respondents were in favour of CF carrier screening, mainly considering the severity of CF, the value of informed reproductive choices and the equality of the screening. All the citizens' juries felt positively about the health service actively offer CF carrier screening to provide women and couples of reproductive age equal access and standardized information on the pros and cons.

CONCLUSION

Considering the favourable attitude towards CF screening, the feasibility of CF screening, in terms of best setting, target age and healthcare professionals providing it, should be tested in a clinical trial.

摘要

背景

在决定是否对囊性纤维化(CF)进行国家携带者筛查时,必须考虑卫生技术评估和伦理问题,并且需要涉及多个利益相关者。公民陪审团是一种让公民参与审议有争议话题的方式,以符合社会利益。该项目的目的是通过公民陪审团的审议来收集有关 CF 携带者筛查的意见,并将其与针对普通人群、CF 患者及其家属和卫生专业人员开放的大型在线咨询调查的结果进行匹配。

方法

三个公民陪审团和一个在线调查被问到:“卫生服务机构是否应该组织对人口进行筛查,以确定可能生育 CF 患儿的健康人群?”陪审员没有医学背景,也没有个人或家族 CF 病史。该调查对 CF 患者、家庭和医疗保健专业人员开放。

结果

陪审员和调查受访者赞成 CF 携带者筛查,主要考虑 CF 的严重性、知情生殖选择的价值以及筛查的平等性。所有公民陪审团都对卫生服务机构积极主动地提供 CF 携带者筛查表示肯定,以便为有生育能力的妇女和夫妇提供平等的机会,并提供有关利弊的标准化信息。

结论

考虑到对 CF 筛查的有利态度,应该在临床试验中测试 CF 筛查的可行性,包括最佳设置、目标年龄以及提供筛查的卫生专业人员。

相似文献

1
Deciding on cystic fibrosis carrier screening: three citizens' juries and an online survey.
Eur J Public Health. 2018 Oct 1;28(5):973-977. doi: 10.1093/eurpub/cky032.
2
Cystic fibrosis: to screen or not to screen? Involving a Citizens' jury in decisions on screening carrier.
Health Expect. 2015 Dec;18(6):1956-67. doi: 10.1111/hex.12261. Epub 2014 Sep 9.
4
The use of citizens' juries in health policy decision-making: a systematic review.
Soc Sci Med. 2014 May;109:1-9. doi: 10.1016/j.socscimed.2014.03.005. Epub 2014 Mar 6.
5
Do consumer voices in health-care citizens' juries matter?
Health Expect. 2016 Oct;19(5):1015-22. doi: 10.1111/hex.12397. Epub 2015 Sep 28.
6
Evaluating the use of citizens' juries in food policy: a case study of food regulation.
BMC Public Health. 2013 Jun 19;13:596. doi: 10.1186/1471-2458-13-596.
7
Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF).
Prenat Diagn. 2001 Jan;21(1):1-9. doi: 10.1002/1097-0223(200101)21:1<1::aid-pd967>3.0.co;2-#.
8
Citizens' juries in planning research priorities: process, engagement and outcome.
Health Expect. 2008 Sep;11(3):272-81. doi: 10.1111/j.1369-7625.2008.00502.x.
10
It is time to update sun safety campaigns to recognise population diversity: Findings from two citizens' juries in Australia.
Health Promot J Austr. 2024 Jul;35(3):609-616. doi: 10.1002/hpja.786. Epub 2023 Aug 7.

本文引用的文献

2
Epidemiology of Cystic Fibrosis.
Clin Chest Med. 2016 Mar;37(1):1-8. doi: 10.1016/j.ccm.2015.10.002.
3
Involving a Citizens' Jury in Decisions on Individual Screening for Prostate Cancer.
PLoS One. 2016 Jan 11;11(1):e0143176. doi: 10.1371/journal.pone.0143176. eCollection 2016.
4
Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues.
Eur J Hum Genet. 2016 Apr;24(4):506-12. doi: 10.1038/ejhg.2015.160. Epub 2015 Jul 29.
5
Cystic fibrosis carrier screening effects on birth prevalence and newborn screening.
Genet Med. 2016 Feb;18(2):145-51. doi: 10.1038/gim.2015.68. Epub 2015 Jun 18.
6
Public awareness on cystic fibrosis: results from a national pragmatic survey.
Eur Respir J. 2015 Jul;46(1):264-7. doi: 10.1183/09031936.00221014. Epub 2015 Apr 16.
7
Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?
Aust N Z J Obstet Gynaecol. 2014 Dec;54(6):503-9. doi: 10.1111/ajo.12255. Epub 2014 Oct 28.
8
Cystic fibrosis: to screen or not to screen? Involving a Citizens' jury in decisions on screening carrier.
Health Expect. 2015 Dec;18(6):1956-67. doi: 10.1111/hex.12261. Epub 2014 Sep 9.
10
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.
Nat Genet. 2013 Oct;45(10):1160-7. doi: 10.1038/ng.2745. Epub 2013 Aug 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验